Login / Signup

Current Clinical Research Directions on Temporomandibular Joint Intra-Articular Injections: A Mapping Review.

Maciej Adam ChęcińskiKamila ChecinskaNatalia TuroszAnita BrzozowskaDariusz ChlubekMaciej Sikora
Published in: Journal of clinical medicine (2023)
This mapping review aims to identify and discuss current research directions on intracavitary temporomandibular joints (TMJs) injections. The inclusion criteria allowed studies published in the last full six years, based on patients diagnosed with temporomandibular joint disorders (TMDs), treated by TMJ intra-articular injections. Medical databases covered by the Association for Computing Machinery, Bielefeld Academic Search Engine, PubMed, and Elsevier Scopus engines were searched. The results were visualized with tables, charts, and diagrams. Of the 2712 records identified following the selection process, 152 reports were qualified for review. From January 2017, viscosupplementation with hyaluronic acid (HA) was the best-documented injectable administered into TMJ cavities. However, a significant growing trend was observed in the number of primary studies on centrifuged blood preparations administrations that surpassed the previously leading HA from 2021.
Keyphrases
  • hyaluronic acid
  • end stage renal disease
  • platelet rich plasma
  • ultrasound guided
  • ejection fraction
  • healthcare
  • prognostic factors
  • peritoneal dialysis
  • emergency department
  • high density